H.C. Wainwright analyst Ed Arce maintained a Hold rating on Galmed Pharmaceuticals (GLMD - Research Report) today. The company's shares closed last Friday at $0.44.According to TipRanks, Arce is a 4-star analyst with an average return of 10.0% and a 40.16% success rate. Arce covers the Healthcare sector, focusing on stocks such as Akebia Therapeutics, Assembly Biosciences, and Pliant Therapeutics.The word on The Street in general, suggests a Hold analyst consensus rating for Galmed Pharmaceuticals with a $1.07 average price target, which is a 142.80% upside from current levels. In a report released today, Canaccord Genuity also downgraded the stock to a Hold with a $1.00 price target.
https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-hold-rating-on-galmed-pharmaceuticals-glmd?utm_source=advfn.com&utm_medium=referral
Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Galmed Pharmaceuticals Charts.
Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Galmed Pharmaceuticals Charts.